Elevated Fibrinogen: Causes, Risks and Treatment

What Is Elevated Fibrinogen?

Fibrinogen is a glycoprotein produced in the liver that plays a key role in blood clotting. It is converted by the enzyme thrombin into fibrin, which forms the structural scaffold of a blood clot. In healthy adults, normal fibrinogen levels range from approximately 200 to 400 mg/dL. When levels consistently exceed this range, the condition is referred to as elevated fibrinogen or hyperfibrinogenemia.

Fibrinogen is also classified as an acute-phase protein, meaning its concentration rises rapidly in response to inflammation, injury, or infection. As a result, elevated fibrinogen is not only a marker of increased clotting tendency but also an indicator of systemic inflammatory processes.

Causes of Elevated Fibrinogen

Elevated fibrinogen levels can result from a wide range of medical conditions and physiological states:

• Acute and chronic inflammation: e.g., rheumatoid arthritis, Crohn's disease, systemic lupus erythematosus
• Infections: bacterial or viral infections with systemic inflammatory responses
• Cardiovascular disease: coronary artery disease, atherosclerosis, increased heart attack risk
• Cancer: many types of cancer trigger elevated acute-phase proteins
• Diabetes mellitus: especially when blood sugar is poorly controlled
• Obesity: excess body weight is associated with elevated inflammatory markers
• Smoking: causes chronic vascular irritation and promotes inflammation
• Pregnancy: physiological increase in clotting factors during gestation
• Hormone therapy: including oral contraceptives or hormone replacement therapy
• Surgery and trauma: postoperative elevation as part of the acute-phase response

Symptoms and Risks

Elevated fibrinogen typically causes no direct symptoms and is most often detected incidentally during routine blood work. However, persistently high fibrinogen levels are associated with an increased risk of several serious conditions:

• Thrombosis: formation of blood clots in veins or arteries
• Heart attack: increased risk due to enhanced clotting tendency and plaque instability
• Stroke: arterial blockages caused by fibrin clots in the brain
• Pulmonary embolism: blockage of pulmonary arteries by dislodged clots
• Microcirculatory disorders: impaired blood flow through small vessels

Elevated fibrinogen is considered a particularly significant risk factor in patients with pre-existing cardiovascular disease or metabolic syndrome.

Diagnosis

Elevated fibrinogen is diagnosed through a simple blood test that measures the concentration of fibrinogen in plasma. Key points for interpretation include:

• The normal reference range is generally 200–400 mg/dL (reference values may vary slightly between laboratories).
• Values above 400–450 mg/dL are considered elevated and warrant further investigation.
• Fibrinogen is often measured as part of a coagulation panel or inflammatory screening (e.g., alongside CRP, ESR, and complete blood count).
• A single elevated value must be interpreted in clinical context, as acute illness can cause a temporary significant increase.

Treatment and Management

Treatment of elevated fibrinogen focuses primarily on addressing the underlying cause. There is no specific therapy that targets fibrinogen levels in isolation without treating the root condition.

Treating the Underlying Condition

When the triggering disease -- such as an infection, rheumatic condition, or diabetes -- is successfully managed, fibrinogen levels often return to normal. Consistent treatment of chronic inflammatory conditions is therefore essential.

Lifestyle Modifications

Several lifestyle changes can help reduce fibrinogen levels and lower cardiovascular risk:

• Smoking cessation: smokers have significantly higher fibrinogen levels than non-smokers.
• Regular physical activity: exercise has been shown to lower fibrinogen levels.
• Weight loss: reducing excess weight decreases systemic inflammation.
• Balanced diet: a Mediterranean-style diet rich in vegetables, fish, and healthy fats has anti-inflammatory effects.
• Alcohol moderation: excessive alcohol consumption can negatively affect inflammatory markers.

Medical Treatment

In high-risk situations, pharmacological intervention may be considered:

• Statins: these cholesterol-lowering drugs also have documented anti-inflammatory effects and may modestly reduce fibrinogen levels.
• Fibrates: a class of lipid-lowering agents that also possess fibrinogen-reducing properties.
• Anticoagulants: when there is a concrete risk of thrombosis, blood-thinning therapy may be indicated to reduce clotting risk.

References

1. Lowe, G. D. O. et al. (2004): Fibrinogen and cardiovascular risk. In: Journal of Internal Medicine, 255(4), 424–431. PubMed PMID: 15049879.
2. World Health Organization (WHO): Cardiovascular diseases – Risk factors and prevention. Available at: https://www.who.int/health-topics/cardiovascular-diseases
3. Danesh, J. et al. (2005): Long-term fibrinogen levels and subsequent coronary heart disease: the EPIC-Norfolk study. In: European Heart Journal, 26(21), 2247–2255. PubMed PMID: 16143707.